Drug profile · INN
leuprolide acetate
LUPANETA PACK
leuprolide acetate (LUPANETA PACK) is a gonadotropin-releasing hormone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
Drug details — leuprolide acetate
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 20
- Programs
- 4
- Data quality
- 0.89
Quick answer
leuprolide acetate (LUPANETA PACK) is a gonadotropin-releasing hormone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12419969
AAV capsid variants and uses thereof
granted -
US 12305189
Compositions and methods for delivery of AAV
granted -
US 12296025
AAV capsid variants and uses thereof
granted -
US 12291565
Tau binding compounds
granted -
US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted -
US 12252703
Closed-ended linear duplex DNA for non-viral gene transfer
granted -
US 12123002
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 12084659
Modulatory polynucleotides
granted -
US 11951121
Compositions and methods for treating Huntington's disease
granted -
US 11859200
AAV capsids with increased tropism to brain tissue
granted -
US 11752181
Compositions and methods of treating Huntington's disease
granted -
US 11603542
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 11542506
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 11512327
Compositions and methods for delivery of AAV
granted -
US 11193129
Modulatory polynucleotides
granted -
US 11066679
Closed-ended linear duplex DNA for non-viral gene transfer
granted -
US 10920227
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 10597660
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 10584337
Modulatory polynucleotides
granted -
US 9617303
Sustained-release composition and method for producing the same
granted
Frequently asked questions
What is leuprolide acetate?
leuprolide acetate (LUPANETA PACK) is a gonadotropin-releasing hormone receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for leuprolide acetate?
LUPANETA PACK is a marketed brand name for leuprolide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of leuprolide acetate?
leuprolide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.